ADVENTRX Pharmaceuticals is a biopharmaceutical company engaged in the development of proprietary product candidates for treating various diseases and conditions. ANX-188, the company’s lead product candidate, is initially being developed as a treatment for complications arising from sickle cell disease … Continue reading →

NanoViricides is a development-stage company engaged in creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide class of drug candidates is designed for the specific purpose of attacking and dismantling enveloped virus particles. NanoViricides is developing drugs against … Continue reading →

DreamTeamGroup, a consortium of unique marketing brands targeted toward investors, will be participating in the sixth annual OneMedForum Conference, taking place Jan. 7-9, 2013, at the Sir Francis Drake Hotel in San Francisco, Calif. The annual OneMedForum Conference is a … Continue reading →